My name is Dimitri Diavatopoulos, I am Dutch, assistant professor at the Department of Laboratory Medicine, theme Infectious diseases and global health.
When you were a kid what did you want to be when you grew up? Can you tell us something about your child years.
I grew up in Lage Zwaluwe, a small town near the Biesbosch. I always wanted to be an astronaut when I grew up. This obviously didn’t work out, but if I ever get the opportunity I would still love to see Earth from space. When I first learned about DNA and cells from my biology teacher in high school I was completely hooked and since then I wanted to become a scientist.
What was your previous academic training, where did you study and why that study?
My undergraduate degree was in Bioprocess Engineering, which I chose mainly because it included a broad curriculum of molecular and cellular biology courses and there was a lot of freedom to pursue my interests. After that I obtained my PhD degree on whooping cough (kinkhoest) at the Utrecht University and the RIVM. I wanted to dive deeper into immunology so I moved to the University of Melbourne where I spent nearly 4 years working on the immunology of viral-bacterial co-infections.
The RIMLS motto is: ‘Today’s molecules for tomorrow’s medicine’. What does this mean for you?
Together with my group we are trying to understand how immune memory to respiratory infections is programmed, how memory evolves over time and how it can be reprogrammed. I am particularly interested in understanding the complex innate signalling networks induced by vaccination and infection and how these are translated into functional adaptive memory responses.
Who is your great example as scientists? And please give a motivation why.
There are many scientists that are a source of inspiration! If I have to name one, it would probably have to be David Schneider, who basically gave me a whole new perspective on how we can deal with infections, involving both tolerance and resistance mechanisms.
Which research discovery that you have made has made you most proud?
It’s probably not so much one discovery but what I am very proud of is my role in bringing together the key researchers in the field of pertussis and getting our consortium funded by the IMI and the Bill & Melinda Gates Foundation. This collaborative effort has really allowed the whole field to move forward, which will be instrumental in bringing pertussis back under control.
Given unlimited finance what experiment would you perform?
We are currently setting up controlled human infection models for different bacterial respiratory tract infections, so when given unlimited funding I would use it to answer some of the many biological questions that we have with these models, including the relationship between systemic and mucosal immunity.
What does your working area (desk, office) look like and what does it say about you (or your research)?
I go through phases, so it really depends. My desk can become cluttered but once every few weeks I take the effort to clean it up. At the moment it’s pretty much OK I think.
Nominate a colleague to be in the spotlight and what would you like to ask him or her?
I would like to nominate my colleague Gerben Ferwerda and ask him why everything always circles back to the type I interferons?
What type of person are you, quick insights:a) Mac or PC? : PC
b) Theater or cinema? : Cinema
c) Dine out or dine in? : Dine in
d) Ferrari or Fiat? : Ferrari…obviously
e) Shopaholic or chocoholic? : Neither
f) Culture or Nature : Nature
Related news items
Exome sequencing in routine diagnostics: a generic test for 254 patients with primary immunodeficiencies18 June 2019
Exome sequencing may provide a genetic diagnosis in a significant number of patients in a single genetic test. Alexander Hoischen and Mihai Netea, theme Infectious diseases and global health, and colleagues, published their results in Genome Medicine.read more
Lowering cholesterol is not enough to reduce hyperactivity of the immune system14 June 2019
In Cell Metabolism, Siroon Bekkering, theme Vascular damage, and colleagues, provides a novel potential explanation for the residual cardiovascular risk, related to persistent activation of the immune system in patients with hypercholesterolemia who are treated with statins.read more
A personal touch of Johan van der Vlag13 June 2019
In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t. This week: Johan van der Vlag.read more